Apellis Pharmaceuticals, Inc. (APLS)
25.84
+0.53
(+2.09%)
USD |
NASDAQ |
Dec 17, 11:54
Apellis Pharmaceuticals Accounts Payable (Quarterly): 38.60M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 413.10M |
| Amicus Therapeutics, Inc. | 19.10M |
| Fortress Biotech, Inc. | 18.77M |
| Ultragenyx Pharmaceutical, Inc. | 40.57M |
| Fulcrum Therapeutics, Inc. | 2.856M |